• 제목/요약/키워드: Thromboelastography

검색결과 12건 처리시간 0.026초

Assessment of coagulation function by thromboelastography in dogs with mitral valve insufficiency

  • Jeong, Chorok;Seo, Minwoong;Chang, Ocki;Park, Jinho;Park, Chul
    • 한국동물위생학회지
    • /
    • 제45권1호
    • /
    • pp.55-61
    • /
    • 2022
  • In veterinary medicine, a variety of disease are known to cause coagulation abnormalities. Identification of these coagulation abnormalities have been relied on traditional coagulation assays(platelet concentration, aPTT, PT, D-dimer, fibrinogen) which take only a small part of the coagulation pathways rather than global hemostatic capacity. Among of the hypercoagulable diseases, cardiovascular disease, such as mitral valvular disease, was not regarded as the cause of the hypercoagulability. The value of a thromboelastography (TEG) as an early predictor of coagulopathy, especially hypercoagulability, has been founded. It was associated with decreased R and K values, and increased MA and α angle. The objective of this study was to compare thromboelastography results and those of traditional coagulation tests between twenty adult dogs with mitral insufficiency (MVI group) and eleven adult healthy dogs (Healthy group). As a results, MA values in the patients with mitral insufficiency (68.8±7.8 mm) were significantly higher than the normal patients (60.4±4.8 mm) (P value<0.05). Although a little report has been reported in veterinary medicine, platelet activation seems to be related with hypercoagulability in MVI patients in human medicine. The result of this report can support this pathophysiology in veterinary medicine. In addition to traditional coagulation assay, global assessment of coagulopathy using TEG, especially ability to detect hypercoagulability, may be useful for customized treatment in MVI patients. To achieve this, further study is needed to define pathophysiology and effect of medication.

Evaluation of Hemostatic Function with Thromboelastography in Dogs with Hypercoagulable Diseases

  • Kim, Ja-Won;Nam, Aryung;Lee, Kyu-Pil;Song, Kun-Ho;Youn, Hwa-Young;Seo, Kyoung-Won
    • 한국임상수의학회지
    • /
    • 제34권2호
    • /
    • pp.65-69
    • /
    • 2017
  • Thromboembolic complications are increasing in veterinary medicine. Thromboelastography (TEG) is a more comprehensive method for assessing the clotting process than standard plasma-based coagulation tests. This study compared the ability of TEG and standard coagulation tests to analyze the overall hemostatic state of dogs. The study involved 40 dogs with underlying diseases that predispose to hypercoagulability, including neoplasia, hyperadrenocorticism, immune-mediated diseases, gastrointestinal diseases, and protein-losing nephropathies and enteropathies, and 20 healthy dogs. Their overall hemostatic functional state was evaluated by TEG and routine coagulation assays, including activated partial thromboplastin time, prothrombin time, platelet count, and D-dimer concentration. TEG analysis showed significant differences in clot formation time, ${\alpha}$ angle, and maximum amplitude (MA) between diseased and control dogs (P < 0.001 each). Increased MA was the most frequent abnormality on TEG and was indicative of hypercoagulability. TEG was useful in detecting hemostatic dysfunction in dogs with diseases associated with hypercoagulability. Dogs with TEG tracings indicative of hypercoagulability are likely to be in procoagulant states. Future prospective studies are needed to evaluate whether TEG tracings indicative of hypercoagulability are predictive of thrombosis in dogs.

Evaluation of Thromboelastography Analysis for Treatment of Heartworm Disease in Dogs over Time: a Pilot Study

  • Han, Donghyun;Yoon, Won-Kyoung;Lee, Hyekyung;Yu, Do-Hyeon;Jung, Dong-In
    • 한국임상수의학회지
    • /
    • 제36권1호
    • /
    • pp.42-45
    • /
    • 2019
  • Thromboelastography (TEG) analysis consists of ${\alpha}$, G, K, MA, and R types of values and tests the effectiveness of blood clotting, which can be assessed for platelet function, clotting strength, and fibrinolysis. Canine heartworm diseases caused by Dirofilaria immitis, a vascular nematode, can lead to hyperfibrinolysis and hypercoagulation. In this study, G and MA values showed a statistically significant decrease over time after treatment of heartworm disease. Additionally, the ${\alpha}-value$ showed a high correlation with G, K, MA, and R values. The G value showed a high correlation with K and MA values, while The K value showed a high correlation with MA and R values. This study clearly found a gradual decrease in G and MA values in dogs with heartworm disease over time, both before and after treatment. This suggests that the clot formation time is longer and that the intensity of clot formation is lowered and may improve the risk of thromboembolism in dogs with heartworm disease.

Hemostatic Dysfunction in a Dog with Mammary Gland Carcinoma

  • Rankyung Jung;Hyeona Bae;ARom Cho;Young Ju Kim;Yeseul Jun;Minji Kim;Sumin Cha;Min-Jeong Kang;Tae-Sung Hwang;Hee-Chun Lee;Kyu-Woan Cho;Dong-In Jung;Dae Young Kim;DoHyeon Yu
    • 한국임상수의학회지
    • /
    • 제39권6호
    • /
    • pp.373-377
    • /
    • 2022
  • Hypercoagulability is the most common coagulopathy seen in dogs with neoplasia, whereas a hypocoagulable state is relatively rare. A 16-year-old spayed female miniature Schnauzer presented with bilateral epistaxis, bilateral hindlimb swelling, and lameness. Previously, the dog was diagnosed with intermediate grade solid carcinoma after mastectomy, and then showed generalized ecchymoses on the abdomen and bilateral hindlimbs on presentation. Laboratory tests revealed a hypocoagulable state, including thrombocytopenia, hypofibrinogenemia, and delayed prothrombin and activated partial thromboplastin time. Thromboelastography demonstrated a prolonged K time with a decreased alpha angle and low maximal amplitude, reflecting a decrease in clot strength. The hypocoagulable state of disseminated intravascular coagulopathy was speculated based on the presence of an underlying tumor, clinical symptoms, and laboratory results of the hypocoagulable state. This case shows the incidence of hemostatic dysfunction as a paraneoplastic syndrome in a dog with mammary gland carcinoma.

개심술 환자의 체외순환 전후 혈전 탄성 묘사도의 임상적 이용 (Clinical Use of Thromboelastography as Monitor of Coagulopathy at the Pre and Post-Cardiopulmonary Bypass)

  • 강경훈;김경훈
    • Journal of Chest Surgery
    • /
    • 제30권11호
    • /
    • pp.1092-1096
    • /
    • 1997
  • 혈전 탄성 묘사도는 일회의 채혈로 지혈기능의 전반적인 평가를 가능하게 하는데, 혈소판 응집과 응괴 강 도와 섬유소 교차결합을 통한 초기의 혈소판-섬유소 상호작용 시간부터 궁극적인 응괴 용해 까지의 단백질 응고 폭포와 혈소판의 상호반응을 기록하는 것이다. 1996년 4월 1일부터 1996년 8월 31일까지 개심술을 받은 35명의 환자를 대상으로(평균 연령 34$\pm$12) 혈전 탄성 묘사도를 수술전, 수술직후, 수술1시간후, 수술 24시간 후에 조사하였다. 전통적인 혈액학적인 지표들과 혈전탄성 묘사도 자료를 통계 분석으로 비교하였다. 체외 순환전의 혈전 탄성 묘사도의 최대 진측과 혈소판 수와, 체외 순환 24시간 후에는 혈전 탄성 묘사도의 R값 및 K값 그리고 알파 앵글이 활성 응고 시간과 통계학적인 의미있는 상관관계가 있었다. 그리고 체외 순환후 24시간 동안의 술후 출혈의 예측 정확도는 혈전 탄성 묘사도가 100%(P=0.0043)로 활성 응고 시간(57%)와 기존의 응고 검사(43%)와 비교해서 더 좋은 방법임을 알 수 있었다. 결론적으로 혈전 탄성 묘사도는 사용이 쉽 고 임상적으로 정확하고 비용면에서 유용하여 지혈문제를 가진 환자에게 효과적으로 처치\ulcorner 수 있는 자료를 제시할 수 있다 하겠다.

  • PDF

심폐바이패스 없이 시행하는 관상동맥우회술 후 혈액응고 기늠의 변화: 심폐바이패스하 관상동맥우회술 후 혈액응고 상태와의 비교 (Changes of Coagulability after Off-pump CABG: Comparison with On-pump CABG)

  • 장우익;김기봉;김욱성;정철현;허재학;장지민;이동순;한규섭
    • Journal of Chest Surgery
    • /
    • 제37권3호
    • /
    • pp.245-251
    • /
    • 2004
  • 심폐바이패스하 관상동맥우회술과 달리 심폐바이패스 없이 시행하는 관상동맥우회술의 경우 수술 후 혈액응고 기능이 항진되어 이식편의 혈전과 같은 문제가 발생되는 것이 우려된다. 비교연구를 통하여 심폐바이패스 없이 시행하는 관상동맥우회술 후 혈액응고기능이 항진되는지를 규명하고자 하였다. 2001년 11월부터 2002년 5월까지 관상동맥우회술을 시행받은 환자 중 심폐바이패스 없이 시행하는 관상동맥우회술을 시행받은 11명(I군, 연구군)과 같은 기간에 좌심실 심첨부와 중격의 무운동성으로 관상동맥우회술과 Dor 술식을 시행받은 11명의 환자들을(II군, 대조군)비교하였다. 술후 혈액응고기능이 항진되는지를 알아보기 위해 thromboelastography 검사를 수술 전, 술 후 1, 2, 3, 5일째 시행하여 r time, k time, $\alpha$ angle, MA값을 측정하였고 동시에 혈액응고기능검사, fibrinogen, D-dimer, protein S, protein C, antithrombin III, plasminogen, 혈소판 수 등을 시행하여 비교하였다. TEG검사의 각각의 변수값과 혈액응고기능검사 중 MA값, $\alpha$ angle, 혈소판수가 양 군 간 의미있는 차이를 보였다. MA값이 I군의 경우 술 후 3일과 5일째 140$\pm$72%와 153$\pm$98%로 증가하였으나 II군의 경우 87$\pm$27%와 78$\pm$28%로 감소하였다(p<0.05). $\alpha$ angle은 술후 3일째 I군이 122$\pm$92%로 증가하였고 II군이 69$\pm$23%로 감소하였다(p=0.09). 혈소판수는 술 후 3일째 I군이 63$\pm$55%였으며 II군이 33$\pm$13%였다(p<0.05). 심폐바이패스하 관상동맥우회술과 비교하여 심폐바이패스 없이 시행하는 관상동맥우회술의 경우 혈액응고기능이 항진되며 따라서 보다 적극적인 항응고치료의 필요성이 제기된다고 할 수 있다.

수혈 감소 전략을 위한 점탄성 응고 검사법의 유용성 (Viscoelastic Coagulation Test Guided Therapy for a Strategy to Reduce Transfusions)

  • 박선영
    • 대한수혈학회지
    • /
    • 제29권3호
    • /
    • pp.240-252
    • /
    • 2018
  • 점탄성 응고 검사법은 전혈 검사법으로 혈장성분뿐 아니라 응고 과정의 세포 기반 측면까지 동시에 볼 수 있는 방법이다. 프로트롬빈시간이나 활성화부분트롬보플라스틴시간과 같은 기존의 응고 검사법과 달리 이 검사는 현장 현시 검사로 즉시 시행할 수 있다. 점탄성 응고 검사법은 사망률 등의 예후 예측 인자이고, 응고 장애를 좀 더 예민하게 감지하여 결과적으로 출혈을 줄여주는 효과를 줄 수 있다. 점탄성 응고 검사 결과를 이용한 수혈 전략이 수혈 요구량을 줄여주었다고 보고되기도 하였다. 아직 이 방법의 정확성과 신뢰도에 대한 우려가 있기도 하지만, ROTEM 등의 점탄성 응고 검사법은 환자혈액관리에 응용하는 것은 유용할 것이다.

Validation of Nafamostat Mesilate as an Anticoagulant in Extracorporeal Membrane Oxygenation: A Large-Animal Experiment

  • Han, Sung Joon;Han, Woosik;Song, Hee-Jung;Kim, Cuk-Seong;Jeong, Seong-Mok;Kang, Min Woong
    • Journal of Chest Surgery
    • /
    • 제51권2호
    • /
    • pp.114-121
    • /
    • 2018
  • Background: Unfractionated heparin is commonly used for anticoagulation in extracorporeal membrane oxygenation (ECMO). Several studies have shown that nafamostat mesilate (NM) has comparable clinical outcomes to unfractionated heparin. This study compared anticoagulation with NM and heparin in a large-animal model. Methods: Beagle dogs (n=8; weight, 6.5-9 kg) were placed on venovenous ECMO. Blood samples were taken every hour and the following parameters were compared: hemoglobin level, activated partial thromboplastin time (aPTT), thromboelastography (TEG) data, platelet function, and inflammatory cytokine levels. Results: In both groups, the aPTT was longer than the baseline value. Although the aPTT in the NM group was shorter than in the heparin group, the TEG parameters were similar between the 2 groups. Hemoglobin levels decreased in both groups, but the decrease was less with NM than with heparin (p=0.049). Interleukin $(IL)-1{\beta}$ levels significantly decreased in the NM group (p=0.01), but there was no difference in the levels of tumor necrosis factor alpha or IL-10 between the 2 groups. Conclusion: NM showed a similar anticoagulant effect to that of unfractionated heparin, with fewer bleeding complications. NM also had anti-inflammatory properties during ECMO. Based on this preclinical study, NM may be a good alternative candidate for anticoagulation in ECMO.

Change in fibrinogen levels and severe postoperative bleeding in cardiac surgery

  • Kim, Eun-Jung;Kim, Joo-Yun;Kim, Hee Young;Hwang, Boo-Young;Cho, Ah-Reum;Jung, Young-Hoon;Baek, Seung-Hoon;Hong, Jeong-Min
    • International Journal of Oral Biology
    • /
    • 제45권2호
    • /
    • pp.51-57
    • /
    • 2020
  • Thromboelastography or rotational thromboelastometry, is being increasingly utilized in cardiac surgery of late. However, it is an indirect test and is not available in all centers. Low fibrinogen levels before and after cardiopulmonary bypass (CPB) have been described to be associated with postoperative bleeding in cardiac surgery. This study explored the usefulness of reduction ratio of the fibrinogen levels before CPB (preCPB) and after CPB (postCPB) in predicting postoperative hemorrhage. A retrospective, observational study of adult patients who underwent cardiac surgery with CPB between February 2014 and January 2016 was conducted, which included a total of 264 patients. The fibrinogen levels were measured twice, preCPB and postCPB, and the fibrinogen reduction ratio was acquired [(preCPB - postCPB)/preCPB]. Postoperative blood loss, which was defined as the blood collected from the chest drain for 12 hours following arrival at the intensive care unit, was considered severe if it was more than 1,000 mL. A multivariate analysis showed that fibrinogen reduction ratio, sex, and postCPB platelet count were significantly associated with severe postoperative bleeding. However, the pre- and postCPB fibrinogen levels were not significantly associated with severe bleeding. Furthermore, a fibrinogen reduction ratio of > 41.3% was independently associated with postoperative severe bleeding, with an odds ratio of 3.472 (1.483-8.162). These results suggest that the reduction ratio of pre- and postCPB fibrinogen levels may be utilized in predicting postoperative bleeding.